Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Improving the Care of Patients with Metastatic Breast Cancer (mBC) Through Innovative Strategies

Pfizer

The National Comprehensive Cancer Network® and Pfizer Global Medical Grants & Partnerships (Pfizer) are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives and implementation to improve the care of patients with metastatic Breast Cancer (mBC). Pfizer (hereafter, “Grantor”) is providing $1.5 Million in funding to support quality improvement projects to advance healthcare quality, the delivery of quality care, and sustainably improve healthcare provider performance in the care of patients with mBC. The Grantor will serve as the funding organization. Grants are only available to healthcare providers from institutions within the United States. All community and academic-based programs, regardless of NCCN affiliation, are eligible and encouraged to apply.

Funding Considerations: • A total of $1.5 Million is available to fund all projects.

• There is a funding cap of $250,000 per project.

• Exceptional proposals with multiple significant collaborating organizations and the potential for wide expansion beyond a single health system may request additional funding above the $250,000 cap.

• Smaller, lower-cost projects are encouraged.

• All budgets must include line-item information and a robust justification.

• Overhead (indirect cost) rates of up to 28% of the total proposed project budget are allowed and must be included in the total requested amount.

• Costs associated with publication of a manuscript and/or travel to present the results of the project at a national meeting will be given consideration for support.

• Applicants are required to disclose additional sources of funding for the proposed project and demonstrate that funding does not overlap.

• Funding decisions are deferred to the members of the external review committee as chosen by NCCN and are independent of Grantor.

Key Dates: • RFP release date: April 21, 2025

• LOI submission deadline: June 9, 2025

• LOI notification date: July 21, 2025

• Proposal submission deadline: September 2, 2025

• Anticipated grant award notification date: End of October 2025 (Please note that the submission deadline is 5:00 PM Eastern)

Specialties

Oncology

Eligibility Requirements

• US community and academic institutions (including NCCN and non-NCCN Member Institutions).

• Health care professional organizations and other organizations related to health care improvement.

• Collaborations should foster the collaborative or multidirectional sharing of knowledge and expertise as well as utilize the combined clinical strengths of members.

• This can also include cross-institutional collaboration for the conduct of quality improvement initiatives.

• Health care delivery organizations must serve as the lead applicant, if partnered with health technology companies.

Additional Eligibility Information:

• Collaboration among academic health care centers and/or community health centers and community organizations is strongly encouraged to foster interactive sharing of knowledge and expertise, and to utilize the combined strengths of the collaborating organizations.

• Junior faculty (i.e., Assistant Professors and below) are encouraged to apply.

• Trainees may participate as a sub-investigator under appropriate mentorship from a PI.

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: Pfizer

Sponsor Type: Corporate/Non-Profit

Address: 66 Hudson Boulevard East New York, NY 10001-2192

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity